Clinical trial

Ultrasound Assessment of Tongue Characteristics in Adolescents With Obesity and Obstructive Sleep Disorders

Opening soon · Not applicable · 1 countries · Registry ID NCT07613944

Opening soonNot applicableInterventional

What this study is about

Obstructive sleep-disordered breathing, including obstructive sleep apnea (OSA), represents a significant yet underdiagnosed condition in the pediatric population, particularly among adolescents with obesity. The tongue is a central anatomical contributor to upper airway collapsibility; however, its biomechanical properties have been investigated almost exclusively in adult populations, leaving a critical gap in knowledge regarding younger individuals. This study aims to assess tongue biomechanical and echographic characteristics using quantitative ultrasound modalities - shear-wave elastography (SWE), acoustic attenuation, and echo intensity - in adolescents aged 12 to 18 years with obesity and obstructive sleep disorders. The study adopts a mixed design combining (1) an observational cross-sectional comparison between participants with obesity and OSDB and age- and sex-matched healthy controls at baseline, and (2) a prospective longitudinal cohort component evaluating changes in tongue ultrasound characteristics over the course of a 30-week multidisciplinary inpatient weight-loss program delivered as standard care at the Zeepreventorium (De Haan, Belgium). An additionnal methodological objective consists in determining intra-rater and inter-rater reliability of the ultrasound acquisition protocol providing a reproducible framework for future studies.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age12 Years to 18 Years
SexAll
Healthy volunteersAccepted
ConditionObesity & Overweight Sleep, Obstructive Sleep Disordered Breathing, Pediatric Obesity

Full registry criteria

Inclusion Criteria: * Aged 12-18 years * Already enrolled in Zeepreventorium weight-loss program as Standard Care Diagnosed Obstructive Sleep Apnea (AHI ≥ 1)1 or any Obstructive sleep disordered breathing detected by any of the specific sleep questionnaire (OSA-18, ESS, SSS-Ad, PDSS) Exclusion Criteria: * Any other orthopedic, traumatic, or rheumatologic condition affecting the cervicocephalic region * Syndromic or neuromuscular disorders * Cognitive impairment limiting compliance with study procedures * Inability to provide informed consent * Self-reported alcohol or recreational drug consumption within 48 hours preceding the experimental session

Treatments and study arms

Submental ultrasound

Device

Tongue ultrasound via a submental approach. This non-invasive, pain-free and non-radiating protocol will study both morphological and dynamic characteristics of the tongue. Ultrasonographic assessment will be performed with participants in a resting, supine position and ultrasound gel will be used to optimise submental probe contact.

Primary outcomes

Tongue stiffnessat baseline and after 30-weeks weight loss program

Tongue stiffness is measured by shear-wave elastography and expressed in kPa.

Tongue thicknessat baseline and after 30 weeks weight loss program

Tongue thickness (expressed in cm) will be measured with ultrasound as the perpendicular distance from the deep fascia of the geniohyoid muscle to the highest lingual dorsum in the midsagittal plane

Echo Intensityat baseline and after a 30 weeks weight loss program

Echo intensity will be measured with ImageJ / Fiji software (ImageJ, US NIH, Bethesda, USA) and refers to the mean value of pixels of an area, based on a grey scale between 0 (black) and 255 (white)

Acoustic Attenuationat baseline and after a 30 weeks weight loss program

Attenuation will be measured with ultrasound and depicts the quantitative measurement of ultrasound attenuation in tissues. It is expressed as an attenuation coefficient in dB/cm/MHz.

Study locations

2 locations were listed when this page was built. The first 40 are shown.

KidZ Health Castle - Universitair Ziekenhuis Brussel Brussels - Health Campus Avenue du Laerbeek 101 1090 Jette🇧🇪 Brussels, Belgium
Inge Gies, MDContact
Frederic Paillaugue, MSc PTContact
Steven Provyn, Prof PhDPrincipal Investigator
Zeepreventorium, Koninklijke Baan 5, 8420 De Haan🇧🇪 De Haan, Belgium
Frederic Paillaugue, MSc PTContact
Steven Provyn, Prof PhDPrincipal Investigator